Delek US (NYSE:DK) Stock Falls 4.1% - Here's Why

Key Points

• Delek US shares fell 4.1% to about $75.25 in light trading, with volume down 91% from its average. The decline came despite the stock remaining above its 50-day and 200-day moving averages.
• Zacks significantly raised several 2026–2028 EPS forecasts, including FY2026 to $13.80 from $9.31 and FY2027 to $11.18 from $5.88, suggesting improved expected operating performance. However, the revisions are analyst-model changes rather than company guidance, and one longer-term estimate was lowered.
• Analyst sentiment remains positive overall, with a “Moderate Buy” consensus and recent price-target increases from Wells Fargo and Goldman Sachs. Risks include Delek’s high debt-to-equity ratio, cyclical refining exposure, and substantial insider selling over the past quarter.

Delek US Holdings, Inc. (NYSE:DK - Get Free Report) was down 4.1% on Tuesday. The company traded as low as $74.22 and last traded at $75.2530. Approximately 136,749 shares changed hands during mid-day trading, a decline of 91% from the average daily volume of 1,574,213 shares. The stock had previously closed at $78.47.

Delek US News Roundup

Here are the key news stories impacting Delek US this week:

• Positive Sentiment: Zacks sharply raised its estimates for several upcoming periods: Q3 2026 EPS increased to $4.19 from $2.05, Q4 2026 to $4.05 from $1.70, and full-year 2026 to $13.80 from $9.31. Estimates for Q1 2027, Q3 2027, Q4 2027, and full-year 2027 were also substantially increased, with FY2027 EPS rising to $11.18 from $5.88. These revisions suggest stronger expected refining or operating performance in the near-to-medium term.
• Positive Sentiment: Zacks also raised its Q1 2028 EPS forecast to $0.23 from $0.14, Q2 2028 to $0.44 from $0.02, and FY2028 to $0.29 from $0.02. The Q2 estimate update was previously reported by Q2 Earnings Estimate for Delek US Issued By Zacks Research
• Neutral Sentiment: The revisions remain analyst-model changes rather than company guidance. Zacks’ current full-year consensus estimate is $18.04 per share, above its own revised FY2026 and FY2027 forecasts, so investors may focus on how DK’s actual results compare with the broader consensus.
• Negative Sentiment: Zacks lowered its Q3 2028 EPS forecast to $0.77 from $0.90, indicating some uncertainty about longer-term profitability. The company’s high debt-to-equity ratio and cyclical refining exposure remain additional risks for investors.

Wall Street Analyst Weigh In

Several research firms have recently commented on DK. Weiss Ratings raised shares of Delek US from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday, October 8th. Mizuho restated a "neutral" rating and issued a $83.00 price objective (up from $66.00) on shares of Delek US in a research report on Thursday, October 8th. Wells Fargo & Company boosted their price objective on shares of Delek US from $82.00 to $95.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 14th. Piper Sandler started coverage on Delek US in a report on Tuesday. They set a "neutral" rating and a $90.00 price objective on the stock. Finally, The Goldman Sachs Group increased their price objective on Delek US from $83.00 to $97.00 and gave the company a "buy" rating in a research report on Thursday, October 15th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $75.00.

Delek US Stock Performance

The firm's 50-day moving average price is $73.35 and its 200 day moving average price is $51.74. The company has a debt-to-equity ratio of 7.53, a quick ratio of 0.47 and a current ratio of 0.76. The company has a market cap of $4.48 billion, a price-to-earnings ratio of 20.55, a PEG ratio of 0.56 and a beta of 0.62.

Delek US (NYSE:DK - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The oil and gas company reported $5.48 earnings per share for the quarter, beating the consensus estimate of $2.67 by $2.81. The business had revenue of $4.09 billion for the quarter, compared to analyst estimates of $3.44 billion. Delek US had a net margin of 1.86% and a return on equity of 109.03%. Delek US's revenue was up 47.9% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.56) earnings per share. On average, sell-side analysts anticipate that Delek US Holdings, Inc. will post 18.04 EPS for the current year.

Insider Buying and Selling at Delek US

In related news, EVP Amber Russell sold 5,392 shares of Delek US stock in a transaction on Friday, September 11th. The stock was sold at an average price of $75.50, for a total transaction of $407,096.00. Following the completion of the sale, the executive vice president directly owned 35,670 shares of the company's stock, valued at $2,693,085. The trade was a 13.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Reuven Spiegel sold 7,500 shares of the company's stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $73.21, for a total value of $549,075.00. Following the completion of the sale, the executive vice president owned 28,935 shares of the company's stock, valued at $2,118,331.35. This represents a 20.58% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 163,377 shares of company stock valued at $11,082,485 over the last quarter. 3.56% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Delek US

Several large investors have recently bought and sold shares of the company. Carolina Wealth Advisors LLC bought a new position in shares of Delek US during the third quarter worth $38,000. Fortitude Family Office LLC increased its position in shares of Delek US by 223.7% in the 3rd quarter. Fortitude Family Office LLC now owns 547 shares of the oil and gas company's stock valued at $39,000 after buying an additional 378 shares in the last quarter. Allworth Financial LP bought a new stake in shares of Delek US in the second quarter worth about $30,000. IFP Advisors Inc raised its position in shares of Delek US by 842.7% during the third quarter. IFP Advisors Inc now owns 707 shares of the oil and gas company's stock worth $50,000 after purchasing an additional 632 shares during the period. Finally, GAMMA Investing LLC raised its position in shares of Delek US by 61.6% during the third quarter. GAMMA Investing LLC now owns 1,183 shares of the oil and gas company's stock worth $84,000 after purchasing an additional 451 shares during the period. Institutional investors own 97.01% of the company's stock.

About Delek US

Delek US Holdings, Inc is a downstream energy company headquartered in Brentwood, Tennessee. The company operates petroleum refineries and related logistics assets, producing and transporting fuels and other refined petroleum products for markets primarily in the southern United States.

Through its refining operations, Delek processes crude oil into products such as gasoline, diesel, jet fuel and asphalt. Its logistics business, conducted in part through Delek Logistics Partners, owns and operates pipelines, crude oil gathering systems, storage terminals, transportation assets and other infrastructure that supports the movement of crude oil and refined products.

Delek has also operated convenience stores and fuel stations, particularly in Texas and neighboring states, under brands including DK and Alon.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.